What is the clinical evidence from this study?

Study design: Meta-Analysis. Population: Dyslipidemia. Intervention: Dyslipidemia. Primary outcome: Pooled prevalence of dyslipidemia (95% CI 41.8-44.1).

What question did this study set out to answer?

To summarize the prevalence, awareness, treatment, control, and risk factors of dyslipidemia in Saudi Arabia.

July 8, 2026Journal of Epidemiology and Global HealthOpen Access

Dyslipidemia in Saudi Arabia: A Systematic Review and Meta-Analysis of Population-Based Studies (2000–2025)

View Full Paper

Ask AI

Bookmark

Key result

Dyslipidemia affects ~43% of Saudi adults, accompanied by low awareness and control rates.

95% CI 41.8-44.1

Population

Observational studies on dyslipidemia in Saudi Arabia (27 studies included, 12 eligible for meta-analysis)

Design

Meta-analysis

Authors

AAAbdulaziz AlkaabbaImam Mohammad ibn Saud Islamic University YAYasir Ibrahim AlsenaidiImam Mohammad ibn Saud Islamic University IAIbrahim Abdullah Bin AhmedImam Mohammad ibn Saud Islamic University

Discussion

Member takes

Implication

Dyslipidemia is highly prevalent (43.0%) in Saudi Arabia but remains inadequately diagnosed, treated, and controlled, highlighting a critical need for national screening and management programs.

Key Points

To summarize the prevalence, awareness, treatment, control, and risk factors of dyslipidemia in Saudi Arabia.
Systematic review of observational studies published from January 2000 to March 2025.
Data extracted and analyzed from six databases following the PRISMA 2020 framework.
Meta-analysis using random-effects modeling conducted on eligible studies.
Pooled prevalence of dyslipidemia was 43.0% (95% CI: 41.8-44.1%) with significant heterogeneity (I² = 97.2%).
Awareness of dyslipidemia was as low as 19%, with treatment coverage below 30%.
Common risk factors included obesity, diabetes, hypertension, and physical inactivity.

Study Design

Type

Meta-Analysis

Structured PICO

Population

Systematic review and meta-analysis of 27 observational studies assessing the prevalence, awareness, treatment, and control of dyslipidemia in Saudi Arabia.

Outcome

Prevalence of dyslipidemia

Dyslipidemia is highly prevalent (43.0%) in Saudi Arabia but remains inadequately diagnosed, treated, and controlled, highlighting a critical need for national screening and management programs.

Limitations

Considerable heterogeneity (I² = 97.2%)
Associations based on cross-sectional data do not imply causality
Most included studies were cross-sectional and of moderate risk of bias
Most included studies were cross-sectional
Moderate risk of bias in most included studies

Cite This Study

Alkaabba et al. (2026) conducted a meta-analysis in Dyslipidemia. Dyslipidemia was evaluated on Pooled prevalence of dyslipidemia (95% CI 41.8-44.1). The pooled prevalence of dyslipidemia in Saudi Arabia was 43.0% (95% CI 41.8-44.1%), though awareness, treatment, and control remain inadequate.

synapsesocial.com/papers/6a4de7d8d2ea289ef6282d15 https://doi.org/10.1007/s44197-026-00603-1

View Full Paper

Ask AI

Bookmark

Implication

Dyslipidemia is highly prevalent (43.0%) in Saudi Arabia but remains inadequately diagnosed, treated, and controlled, highlighting a critical need for national screening and management programs.

Dyslipidemia in Saudi Arabia: A Systematic Review and Meta-Analysis of Population-Based Studies (2000–2025)

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Limitations

Cite This Study

Dyslipidemia in Saudi Arabia: A Systematic Review and Meta-Analysis of Population-Based Studies (2000–2025)

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Limitations

Cite This Study

Also Consider

Also Consider